CSL - Current Liabilities


CSL reported $4.61B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Arca Biopharma USD 16.63M 1.26M Mar/2026
aTyr Pharma USD 11.7M 101.49M Mar/2026
Bio Path USD 9.15M 468K Mar/2026
Brainstorm Cell Therapeutics USD 11.76M 757K Mar/2026
Cara Therapeutics USD 11.26M 216K Mar/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
Immunic USD 38.36M 7.74M Mar/2026
Minerva Neurosciences USD 2.29M 381K Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
TherapeuticsMD USD 5.82M 655K Jun/2024